Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals

Saudi Medical Journal

Volumn 25, Issue 3, 2004, Pages 313-317

  Al Jabri, Ali A ^a   Al Buloshi, Mohammed S ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOLOGY; MALE; NORMAL HUMAN; OMAN; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; SEX DIFFERENCE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; OMAN;

EID: 1842789112     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reyes H, Dearing L, Bick RL, Shoenfeld Y, Peter JB. Laboratory diagnosis of antiphospholipid syndromes. Clin Lab Med 1995; 15: 85-108.
2. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996; 39: 1444-1454.
3. Khamashta MA, Hughes GRV. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995; 7: 389-394.
4. Abu-Shakra M, Gladman DD, Urowitz MB, Farewell V. Anticardiolipin antibodies in systemic lupus erythematosus: Clinical and laboratory correlations. Am J Med 1995; 99: 624-628.
5. Garcia-Monco JC, Wheeler CM, Benach JL, Furie RA, Lukehart SA, Stanek G et al. Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci 1993; 117: 206-214.
6. Yodfat O, Blank M, Krause I, Shoenfeld Y. The pathogenic role of anti-phosphatidylserine antibodies: Active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Clin Immunol Immunopathol 1996; 78: 14-20.
7. Barka N, Reagan K, Agopian M, Peter JB. Frequency of anticardiolipin and antiphosphatidylserine antibodies in patients with suspected antiphospholipid syndrome. Clin Chem 1995; 41: 5-73.
8. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 1990; 20: 231-236.
9. El-Roeiy A, Gleicher N. Definition of normal autoantibody levels in an apparently healthy population. Obstet Gynecol 1988; 72: 596-602.
10. Jones JV, Eastwood BJ, Jones E, James H, Mansour M. Antiphospholipid antibodies in a healthy population: Methods for estimating the distribution. J Rheumatol 1995; 22: 55-61.
11. Chakravarty KK, Gray RE, Webley M, Byron MA, Wozniak J. Prevalence of anticardiolipin antibodies in the elderly British population. Postgrad Med J 1991; 67: 358-361.
12. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJE, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.
13. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
14. Salazar-Paramo M, Jara LJ, Ramos A, Barile L, Machado G, Garcia-De La Torre I. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Rheumatol Int 2002; 22: 142-147.
15. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
16. Al-Jabri AA, Richens ER. Occurrence of auoantibodies within healthy Omani individuals. S Q U J Med Sciences 2001; 1: 13-19.
17. Harris EN, Pierangeli SS. Functional effects of anticardiolipin antibodies. Lupus 1996; 5: 372-377.
18. Erkkila AT, Narvanen O, Lehto S, Uusitupa MI, Yla-Herttuala S. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 204-209.
19. Grabbar P. Autoantibodies and physiologic role of immunoglobulins. Immunol Today 1984; 4: 337.
20. Andelova K, Sula K, Velebil P. Importance of anticardiolipin antibody screening in pregnancy. Ceska Gynekol 1998; 83: 446-449.
21. Hams EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-2156.
22. Stemberg AD, Krieg AM, Gourky MF. Theoretical and experimental approaches to generalized autoimmunity. Immunol Rev 1990; 118: 129-143.
23. Cabiedes J, Trejo-Hemandez J, Loredo-Abdala A, Castilla-Serna L, Lopez-Mendoza AT, Cordero-Esperon HA et al. Anti-cardiolipin, anti-cardiolipin plus bovine, or human beta(2)glycoprotein-I and anti-human beta(2) glycoprotein-I antibodies in a healthy infant population. Arch Med Res 2002; 33: 175-179.